Evommune

MeiraGTx is a clinical-stage genetic medicine company based in New York that is dedicated to unlocking the potential of genetic therapies for both rare and prevalent diseases. The company employs pioneering technologies, including a unique riboswitch gene regulation platform, to achieve precision control of gene expression, which can transform the treatment landscape for various disorders. With a commitment to improving patient lives, MeiraGTx integrates advanced science and an extensive manufacturing ecosystem to provide tailored treatments. Their diverse clinical pipeline reflects the company's focus on addressing inherited and non-inherited diseases through innovative approaches to genetic medicine. Generated from the website

Basepair is a New York City-based company specializing in Next Generation Sequencing (NGS) data analytics, offering scalable solutions designed to simplify and expedite analysis workflows without the need for costly computing resources or specialized personnel. Their intuitive online platform serves a diverse clientele, including leading academic institutions, research centers, and companies across various sectors such as consumer genomics, biotechnology, pharmaceuticals, and agri-genomics. In partnership with TATAA Biocenter, Basepair enhances NGS data analysis by providing a fast and accessible tool that caters to both commercial and academic needs, significantly reducing the analysis time for workflows like RNA-Seq and DNA-Seq. The collaboration emphasizes user-friendly features, allowing even those without computer science backgrounds to efficiently conduct data analysis with just a few clicks. Generated from the website